PRS41 - COST-EFFECTIVENESS OF PIRFENIDONE FOR THE TREATMENT OF PATIENTS WITH MILD TO MODERATE IDIOPATHIC PULMONARY FIBROSIS IN GREECE
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2435
https://www.valueinhealthjournal.com/article/S1098-3015(18)35737-1/fulltext
Section Title :
Section Order :
1792
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35737-1&doi=10.1016/j.jval.2018.09.2435